Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
about
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsAdvanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cellsOrally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyCurrent perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementType 2 diabetes and cognitive impairment: linking mechanismsDiabetic Kidney Disease: Pathophysiology and Therapeutic TargetsDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing miceAdvanced glycation: an important pathological event in diabetic and age related ocular diseaseAdvanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathwayPimagedine: a novel therapy for diabetic nephropathy.[Protein glycation as a pathological mechanism in diabetes].Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats.Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisHuman glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.Dietary Metabolites and Chronic Kidney Disease.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cellsRole of transcription factor acetylation in diabetic kidney disease.Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Alterations in T2 relaxation magnetic resonance imaging of the ovine intervertebral disc due to nonenzymatic glycation.Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse.Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidineTherapeutic potential of anti-oxidants and diabetic retinopathy.Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.Advanced glycation and the immune system: stimulation, inhibition or both?Endothelial dysfunction in children with type 1 diabetes mellitus.-374 T/A RAGE polymorphism is associated with chronic kidney disease progression in subjects affected by nephrocardiovascular disease.Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy.Caloric restriction mimetics: metabolic interventions.Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control.Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophyImproved diabetes control in the elderly delays global cognitive declineGlycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisChronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats.
P2860
Q24561776-F9D45CC3-598F-49AE-B14A-2698BE0926CAQ24563997-DBE902AC-C45B-4BD9-9570-727FB83E393FQ24682750-6F2BAB01-9EB0-44DA-B8F1-656FD7C51B59Q26781156-7149910B-8A9D-4D6F-BD48-9D252807C981Q26822993-7469E257-01C3-4F13-A26B-1B93D9C578F6Q28086840-B1CB6882-1473-4BED-A3FB-987D69BEFFB6Q28344139-9141D75C-6559-4661-AE37-2AF00DA9BAC5Q28365776-FB44D85F-F90E-46A4-9DB9-A2EB6816DAECQ28366662-A3D25378-AB17-484F-A182-C398D4D3B0A5Q28566602-E1B2CEBF-7026-40BC-9771-94E2E934AABAQ30309168-EBC24B7E-8E2F-4787-A8CE-DF6B94DAFF6FQ30318169-E2BB97B2-6C61-4B91-ACEF-52E2BB19AE7AQ31036740-5B0E5979-806B-4D81-A809-8C175A14471AQ31818138-240D46E7-2004-4CDB-9863-BD7B398E100DQ32085442-FBC9CDD4-5BE9-4FEA-8109-FD76B4ACA81FQ33589138-9A1642E2-BD5F-4610-8B6B-E225D6801BBFQ33616732-110F283F-7BF6-4100-B921-8736A7039B11Q33633674-565A8309-F759-46F6-93BF-D8975EB6BF7CQ33691339-B7C244FD-030D-424D-B325-EE32AB1515C1Q33744838-7E37F973-F440-4943-A06B-E3FFE59A6BB5Q33789303-A23C93A4-D070-43F8-9447-11A08D508A22Q33793187-A4DAE74A-F4CF-40E7-BC63-DC0B54C2C5FEQ33998584-E07DB855-CE1F-497E-8C79-2EF268BBE50AQ34024334-E46BED69-C502-4CC4-BF55-43201496E3FBQ34374197-73FC56DF-91E2-4AF2-9A13-5860111F8B2AQ34481705-C4AEE4D8-C67B-4E3D-B7DF-2E6EE1E29AC3Q34481838-8367A02C-EA3D-4DC4-84AB-DD5B1059ACD2Q34570629-3F40E7B1-9460-4FEF-890F-D6290939DC3FQ34636106-16BF47A0-FACD-447A-A8DA-4CCB8B7232DBQ34672674-4B9FB6DE-9897-4A25-83A6-816ED5D6091EQ34682233-66879141-3246-4B62-84B5-A39448D8E4D5Q34712074-204ABEF5-AEA2-423A-AA3C-AA817D461136Q34981419-A34B1BEA-8022-4721-A239-DB6630676FC9Q35095210-0153DE90-3153-4916-980D-AF5318D55579Q35103591-1C52FC85-290E-4EDF-AB8F-95686692C582Q35764706-80C19A88-A6EB-4EE4-9981-7137FF4C839AQ35805813-0EA0BEC9-1922-467B-8A50-B4E36779E3FEQ35895265-2B76D8FD-7B06-4DA1-AD36-2364B4DA7C47Q36052417-5311EFC7-9354-49C2-93FD-5718F66E5E76Q36072742-670AF6ED-DCB8-4E4E-9A5E-1FC3D76FD8E7
P2860
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Advanced glycation end product ...... and albuminuria in normal rats
@ast
Advanced glycation end product ...... and albuminuria in normal rats
@en
type
label
Advanced glycation end product ...... and albuminuria in normal rats
@ast
Advanced glycation end product ...... and albuminuria in normal rats
@en
prefLabel
Advanced glycation end product ...... and albuminuria in normal rats
@ast
Advanced glycation end product ...... and albuminuria in normal rats
@en
P2093
P2860
P356
P1476
Advanced glycation end product ...... and albuminuria in normal rats
@en
P2093
P2860
P304
11704-11708
P356
10.1073/PNAS.91.24.11704
P407
P577
1994-11-01T00:00:00Z